The 10 Worst-Performing Stocks on Monday

1. BridgeBio Pharma Inc. (NASDAQ:BBIO)

BridgeBio Pharma’s shares plummeted by 9.3 percent on Monday to finish at $31.03 each after one of its largest investors, Global Investors Lp Viking, disposed of 3.06 million shares in the company for a transaction worth nearly $107 million. The sell-off marked a 12-percent slash in its ownership in BridgeBio.

Following the sale, Global Investors now owns 22 million shares of BridgeBio’s stock, valued at $769.7 million.

BridgeBio Pharma is a commercial-stage biopharmaceutical company committed to the discovery, development, and commercialization of pioneering medicines for patients with genetic diseases and genetically driven cancers. By leveraging cutting-edge science and a deep understanding of genetics, the company aims to provide targeted, transformative treatments that address the root causes of these conditions.

While we acknowledge the potential of BBIO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than BBIO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.